Ventoline 0

DRUG2 trials

Sponsors

Assistance Publique Hopitaux De Paris, Assistance Publique Hopitaux De Paris, Vaestra Goetalandsregionen, Vaestra Goetalandsregionen

Conditions

Amyotrophic Lateral Sclerosis (ALS)Congenital myopathy

Phase 2

WALKALS : A pilot phase II study to evaluate the effect of salbutamol on walking capacity in ambulatory ALS patients.

Not yet recruitingCTIS2022-501624-14-00

Assistance Publique Hopitaux De Paris, Assistance Publique Hopitaux De ParisAmyotrophic Lateral Sclerosis (ALS)

Target: 36Updated: 2023-08-18

Phase 4

COMPIS - Congenital myopathy intervention study. An open-label, cross over, randomized, controlled study using salbutamol

CompletedCTIS2024-512027-36-00

Vaestra Goetalandsregionen, Vaestra GoetalandsregionenCongenital myopathy

Start: 2021-09-27End: 2025-03-17Target: 20Updated: 2024-10-28